Showing results (1511-1520 of 1,553) with videos related to

Sort By:
Pageof 156
The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.
Therapeutic Advances in Medical Oncology|July 10, 2026
Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensusPei-Hung Chang, Meng-Che Hsieh, Hao-Wei Teng, et al.
The Lancet. Oncology|May 16, 2022
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialJie Wang, Caicun Zhou, Wenxiu Yao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Advances in Wound Care|May 23, 2024
Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Post Hoc AnalysisShun-Cheng Chang, Ching-Wen Lin, Jui-Ching Chen, et al.
EMBO Molecular Medicine|September 19, 2019
Nuclear receptor corepressor 1 represses cardiac hypertrophyChao Li, Xue-Nan Sun, Bo-Yan Chen, et al.
Cancer Communications (London, England)|October 2, 2025
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trialsJian Li, Ting Deng, Yanhong Gu, et al.
Thoracic Cancer|December 22, 2021
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in ChinaYuequan Shi, Jian Fang, Chengzhi Zhou, et al.
Chinese Journal of Integrative Medicine|June 20, 2022
Analysis of Chinese Medical Syndrome Features of Ischemic Stroke Based on Similarity of Symptoms SubgroupXiao-Qing Liu, Run-Shun Zhang, Xue-Zhong Zhou, et al.
The New England Journal of Medicine|October 22, 2025
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLCWenfeng Fang, Lin Wu, Xiangjiao Meng, et al.
Pageof 156